PUBMED FOR HANDHELDS

Journal Abstract Search


356 related items for PubMed ID: 18847426

  • 1. [Advances in primary glomerular disease in 2007].
    Ara J.
    Nefrologia; 2008; 28 Suppl 5():85-9. PubMed ID: 18847426
    [Abstract] [Full Text] [Related]

  • 2. The impact of sex in primary glomerulonephritis.
    Cattran DC, Reich HN, Beanlands HJ, Miller JA, Scholey JW, Troyanov S, Genes, Gender and Glomerulonephritis Group.
    Nephrol Dial Transplant; 2008 Jul; 23(7):2247-53. PubMed ID: 18182409
    [Abstract] [Full Text] [Related]

  • 3. [Immunosuppressive therapy of glomerulonephritis--controlled studies].
    Ferrari P, Frey FJ.
    Ther Umsch; 1993 Feb; 50(2):119-29. PubMed ID: 8456416
    [Abstract] [Full Text] [Related]

  • 4. Idiopathic membranous nephropathy: diagnosis and treatment.
    Fervenza FC, Sethi S, Specks U.
    Clin J Am Soc Nephrol; 2008 May; 3(3):905-19. PubMed ID: 18235148
    [Abstract] [Full Text] [Related]

  • 5. Idiopathic membranous nephropathy: outline and rationale of a treatment strategy.
    du Buf-Vereijken PW, Branten AJ, Wetzels JF.
    Am J Kidney Dis; 2005 Dec; 46(6):1012-29. PubMed ID: 16310567
    [Abstract] [Full Text] [Related]

  • 6. [Steroid-responsive nephrotic syndrome in IgA nephropathy].
    García Camín RM, Cabezas A, Calero F, Ballarín JA.
    Nefrologia; 2004 Dec; 24 Suppl 3():68-71. PubMed ID: 15219073
    [Abstract] [Full Text] [Related]

  • 7. [Treatment of idiopathic membranous nephropathy. Is the anti-CD20 antibody rituximab a reasonable option?].
    Busch M, Gerth J, Ott U, Schip A, Haufe CC, Gröne HJ, Wolf G.
    Med Klin (Munich); 2008 Jul 15; 103(7):519-24. PubMed ID: 18604487
    [Abstract] [Full Text] [Related]

  • 8. Tacrolimus improves the proteinuria remission in patients with refractory IgA nephropathy.
    Zhang Q, Shi SF, Zhu L, Lv JC, Liu LJ, Chen YQ, Zhang H, Wang HY.
    Am J Nephrol; 2012 Jul 15; 35(4):312-20. PubMed ID: 22456060
    [Abstract] [Full Text] [Related]

  • 9. [Problems with immunosuppressive agents in nephropathies with chronic renal failure].
    Savoldi S, Mesiano P, Rocchietti M.
    G Ital Nefrol; 2008 Jul 15; 25 Suppl 44():S38-S47. PubMed ID: 19048585
    [Abstract] [Full Text] [Related]

  • 10. Long-term outcomes of idiopathic membranous nephropathy in Japanese patients treated with low-dose cyclophosphamide and prednisolone.
    Eriguchi M, Oka H, Mizobuchi T, Kamimura T, Sugawara K, Harada A.
    Nephrol Dial Transplant; 2009 Oct 15; 24(10):3082-8. PubMed ID: 19465558
    [Abstract] [Full Text] [Related]

  • 11. [Membranous kidney diseases in adults].
    Sobarzo Toro M, Vilches A.
    Medicina (B Aires); 2004 Oct 15; 64(1):59-65. PubMed ID: 15034960
    [Abstract] [Full Text] [Related]

  • 12. Beta-2-microglobulin is superior to N-acetyl-beta-glucosaminidase in predicting prognosis in idiopathic membranous nephropathy.
    Hofstra JM, Deegens JK, Willems HL, Wetzels JF.
    Nephrol Dial Transplant; 2008 Aug 15; 23(8):2546-51. PubMed ID: 18308774
    [Abstract] [Full Text] [Related]

  • 13. Corticosteroids and ciclosporin A in idiopathic membranous nephropathy: higher remission rates of nephrotic syndrome and less adverse reactions than after traditional treatment with cytotoxic drugs.
    Goumenos DS, Katopodis KP, Passadakis P, Vardaki E, Liakopoulos V, Dafnis E, Stefanidis I, Vargemezis V, Vlachojannis JG, Siamopoulos KC.
    Am J Nephrol; 2007 Aug 15; 27(3):226-31. PubMed ID: 17389782
    [Abstract] [Full Text] [Related]

  • 14. Remission of proteinuria improves prognosis in IgA nephropathy.
    Reich HN, Troyanov S, Scholey JW, Cattran DC, Toronto Glomerulonephritis Registry.
    J Am Soc Nephrol; 2007 Dec 15; 18(12):3177-83. PubMed ID: 17978307
    [Abstract] [Full Text] [Related]

  • 15. The treatment of idiopathic membranous nephropathy.
    Geddes CC, Cattran DC.
    Semin Nephrol; 2000 May 15; 20(3):299-308. PubMed ID: 10855940
    [Abstract] [Full Text] [Related]

  • 16. Treatment-related changes in urinary excretion of high and low molecular weight proteins in patients with idiopathic membranous nephropathy and renal insufficiency.
    du Buf-Vereijken PW, Wetzels JF.
    Nephrol Dial Transplant; 2006 Feb 15; 21(2):389-96. PubMed ID: 16234291
    [Abstract] [Full Text] [Related]

  • 17. [Treatment of IgA nephropathy].
    Matousovic K, Mestecky J, Tomana M, Novak J.
    Vnitr Lek; 2008 Mar 15; 54(3):239-44. PubMed ID: 18522291
    [Abstract] [Full Text] [Related]

  • 18. Early initiation of tacrolimus or cyclophosphamide therapy for idiopathic membranous nephropathy with severe proteinuria.
    Li X, Lv R, He Q, Li H, Du X, Lin W, Li Q, He X, Wang S, Chen J.
    J Nephrol; 2008 Mar 15; 21(4):584-91. PubMed ID: 18651550
    [Abstract] [Full Text] [Related]

  • 19. Remission of proteinuria in primary glomerulonephritis: we know the goal but do we know the price?
    Philibert D, Cattran D.
    Nat Clin Pract Nephrol; 2008 Oct 15; 4(10):550-9. PubMed ID: 18725916
    [Abstract] [Full Text] [Related]

  • 20. Vasculitic IgA nephropathy: prognosis and outcome.
    Pankhurst T, Lepenies J, Nightingale P, Howie AJ, Adu D, Harper L.
    Nephron Clin Pract; 2009 Oct 15; 112(1):c16-24. PubMed ID: 19342865
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 18.